Peptide-based bio corporations Caregen on the 1st will disclose the U.S. Food and Drug Administration (FDA) phase 1 clinical trial results for "CG-P5," a candidate treatment for wet age-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback